-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Hold on Harmony Biosciences Hldgs, Raises Price Target to $34

Benzinga·08/05/2026 18:17:07
Listen to the news
Truist Securities analyst Danielle Brill maintains Harmony Biosciences Hldgs (NASDAQ:HRMY) with a Hold and raises the price target from $29 to $34.